Health Care & Life Sciences » Biotechnology | Medpace Holdings Inc.

Medpace Holdings Inc. | Balance Sheet

Fiscal year is January-December. All values USD Millions.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
-
55
18
37
26
23
Total Accounts Receivable
-
65
65
80
83
133
Other Current Assets
-
13
12
16
20
21
Total Current Assets
-
133
95
133
130
178
Net Property, Plant & Equipment
-
38
38
44
49
52
Intangible Assets
-
920
848
797
760
730
Other Assets
-
5
4
5
6
7
Total Assets
-
1,097
984
979
951
968
ST Debt & Current Portion LT Debt
-
-
-
12
17
Accounts Payable
-
6
9
11
17
Other Current Liabilities
-
127
125
145
160
Total Current Liabilities
-
134
134
169
193
Long-Term Debt
-
523
408
180
232
Deferred Taxes
-
34
21
12
6
Other Liabilities
-
4
7
8
22
Total Liabilities
-
695
571
368
447
Common Equity (Total)
-
402
413
611
504
Total Shareholders' Equity
-
402
413
611
504
Total Equity
-
402
413
611
504
Liabilities & Shareholders' Equity
-
1,097
984
979
951

About Medpace Holdings

View Profile
Address
5375 Medpace Way
Cincinnati Ohio 45227
United States
Employees -
Website http://www.medpace.com
Updated 07/08/2019
Medpace Holdings, Inc. engages in the research, development, and trading of medical device and pharmaceutical products. Its services include medical affairs, clinical trial management, study feasibility, study-start-up, clinical monitoring, global regulatory affairs, medical writing, biometrics, pharmacovigilance, core laboratory, laboratories, clinics, and quality assurance. The company was founded by August J.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.